PPHM

Most active Nasdaq-traded stocks

moreView todays social media effects on PPHMView the latest stocks trending across Twitter. Click to view dashboardSee who Peregrine is hiring next, click here to view […]

Most active Nasdaq-traded stocks

moreView todays social media effects on PPHMView the latest stocks trending across Twitter. Click to view dashboardSee who Peregrine is hiring next, click here to view […]

8:06 am Peregrine Pharma: Data Presented at AACR support potential of combining Peregrine’s PS-targeting immunotherapy agent Bavituximab with irradiation in Lung Cancer

moreView todays social media effects on PPHMView the latest stocks trending across Twitter. Click to view dashboardSee who Peregrine is hiring next, click here to view […]

4:00 pm Peregrine Pharma: PS-targeting immunotherapy platform to be highlighted in three data presentations at Keystone Symposia Conferences

moreView todays social media effects on PPHMView the latest stocks trending across Twitter. Click to view dashboardSee who Peregrine is hiring next, click here to view […]

Peregrine Pharmaceuticals to Report Third Quarter Fiscal Year 2014 Financial Results Before Market Open on March 7, 2014

[Marketwired] – Peregrine Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, today announced that it will … moreView todays social media effects on PPHMView the latest stocks trending across Twitter. Click to view dashboardSee who Peregrine is hiring next, click here to view […]

Peregrine Pharmaceuticals Announces Partial Exercise of Overallotment Option in Connection With Preferred Stock Offering

[Marketwired] – Peregrine Pharmaceuticals, Inc. , announced today that the underwriters of its underwritten public offering of its 10.50% Series E Convertible Preferred Stock have partially exercised their option to cover … moreView todays social media effects on PPHMView the latest stocks trending across Twitter. Click to view dashboardSee who Peregrine is hiring next, click here to view […]

Peregrine Pharmaceuticals Announces Partial Exercise of Overallotment Option in Connection With Preferred Stock Offering

[Marketwired] – Peregrine Pharmaceuticals, Inc. , announced today that the underwriters of its underwritten public offering of its 10.50% Series E Convertible Preferred Stock have partially exercised their option to cover … moreView todays social media effects on PPHMView the latest stocks trending across Twitter. Click to view dashboardSee who Peregrine is hiring next, click here to view […]